foxo4 dri cancer foxo4-dri senolytic peptide human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cell-specific apoptosis Frontiers The disordered p53 transactivation domain
Pay in 4 interest-free payments of $6.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15


























